Back to User profile » Prof. Dr. Ying Yuan
Papers published by Prof. Dr. Ying Yuan:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer
Qin S, Xu RH, Shen L, Xu J, Bai Y, Yang L, Deng Y, Chen ZD, Zhong H, Pan H, Guo W, Shu Y, Yuan Y, Zhou J, Xu N, Liu T, Ma D, Wu C, Cheng Y, Chen D, Li W, Sun S, Yu Z, Cao P, Chen H, Wang J, Wang S, Wang H, Wang N, Zhang B, Zhang Q, Su W, Guo X, Li J
OncoTargets and Therapy 2021, 14:4439-4450
Published Date: 11 August 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Deguelin induces apoptosis in colorectal cancer cells by activating the p38 MAPK pathway
Chen L, Jiang K, Chen H, Tang Y, Zhou X, Tan Y, Yuan Y, Xiao Q, Ding K
Cancer Management and Research 2019, 11:95-105
Published Date: 20 December 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma
![](cr_data/cache/submission_images/s154000/154567/16_jul_2018_154567_fig2_200_200_90.jpg)
Li X, Li X, Fang X, Yuan Y
OncoTargets and Therapy 2018, 11:4047-4050
Published Date: 16 July 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
Zhu L, Li X, Shen Y, Cao Y, Fang X, Chen J, Yuan Y
OncoTargets and Therapy 2016, 9:4879-4886
Published Date: 8 August 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical impacts of a micropapillary pattern in lung adenocarcinoma: a review
Cao Y, Zhu LZ, Jiang MJ, Yuan Y
OncoTargets and Therapy 2016, 9:149-158
Published Date: 31 December 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Critical appraisal of the role of gefitinib in the management of locally advanced or metastatic non-small cell lung cancer
Yuan Y, Li XF, Chen JQ, Dong CX, Weng SS, Huang JJ
OncoTargets and Therapy 2014, 7:841-852
Published Date: 28 May 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
How to detour Treg cells in T cell-based antitumor immune therapy
Zheng S, Shen Y, Song Y, Yuan Y
OncoTargets and Therapy 2013, 6:1243-1247
Published Date: 6 September 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Evaluation of therapeutic effect of tumor-targeted therapy
Li XF, Li MD, Shen H, Fang XF, Huang PT, Yuan Y
OncoTargets and Therapy 2012, 5:191-198
Published Date: 17 September 2012